CN Patent

CN112174955B — 一种2-取代-5-六氢哒嗪酮-4-羧酸胺衍生物及其用途

Assigned to GUANGZHOU NANXIN PHARMACEUTICAL CO Ltd · Expires 2023-01-13 · 3y expired

What this patent protects

本发明属于药物领域，具体涉及一种2‑取代‑5‑六氢哒嗪酮‑4‑羧酸胺衍生物，其化合物及其药学上可接受的盐、溶剂化物包括水合物、多晶体、前药、共晶体、互变异构物、立体异构体，更具体地说，本发明所述的化合物可以作为具有CEN抑制作用的抗流感药物。

USPTO Abstract

本发明属于药物领域，具体涉及一种2‑取代‑5‑六氢哒嗪酮‑4‑羧酸胺衍生物，其化合物及其药学上可接受的盐、溶剂化物包括水合物、多晶体、前药、共晶体、互变异构物、立体异构体，更具体地说，本发明所述的化合物可以作为具有CEN抑制作用的抗流感药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN112174955B
Jurisdiction
CN
Classification
—
Expires
2023-01-13
Drug substance claim
No
Drug product claim
No
Assignee
GUANGZHOU NANXIN PHARMACEUTICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.